TARS Tarsus Pharmaceuticals, Inc. - Common Stock
$72.44
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$48–$84
68% of range
分析师评级
STRONG BUY
15 analysts
目标价
$95
+31% upside
P/E (TTM)
-46.1
ROE
-19.7%
净利润率
-14.7%
TARS 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$72.44
市值
$3.12B
P/E (TTM)
-46.1
每股收益 (TTM)
$-1.59
营收 (TTM)
$451M
股息收益率
—
ROE
-19.7%
负债/权益
0.2
52周区间
$48 – $84
TARS 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$451M
2020-12-31
→
2025-12-31
EPS
$-1.59
2020-12-31
→
2025-12-31
自由现金流
$-22M
2020-12-31
→
2025-12-31
利润率
-14.7%
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
TARS
同行中位数
P/E (TTM)
-46.1
29.4
P/S (TTM) (市销率 (TTM))
6.9
4.9
P/B (市净率)
9.1
6.5
EV / EBITDA (企业价值 / EBITDA)
-39.1
—
Price / FCF (股价/自由现金流)
-139.7
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
TARS
同行中位数
Operating Margin (营业利润率)
-15.7%
—
Net Profit Margin (净利润率)
-14.7%
-9.0%
ROA
-14.1%
-8.2%
ROE
-19.7%
-19.4%
ROIC
-17.6%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
TARS
同行中位数
Debt / Equity (负债/股东权益比率)
0.2
—
Current Ratio (流动比率)
3.9
3.6
Quick Ratio (速动比率)
3.7
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
TARS
同行中位数
Revenue YoY (营收同比增长)
146.7%
—
Revenue CAGR 3Y (营收3年复合年增长率)
159.5%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
TARS
同行中位数
TARS 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
15 位分析师
- 强烈买入 7 46.7%
- 买入 7 46.7%
- 持有 1 6.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
7 位分析师 · 2026-08-19
中位数
$99.00
平均值
$94.86
← 低于所有目标
$72.44
最低
$84.00
最高
$104.00
中位数目标
$99.00
+36.7%
平均目标
$94.86
+30.9%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.01%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.49 | $-0.20 | -0.29% |
| 2026年3月31日 | $-0.16 | $-0.38 | 0.22% |
| 2025年12月31日 | $-0.20 | $-0.10 | -0.10% |
| 2025年9月30日 | $-0.30 | $-0.36 | 0.06% |
| 2025年6月30日 | $-0.48 | $-0.41 | -0.07% |
| 2025年3月31日 | $-0.64 | $-0.75 | 0.11% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 15
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M | $0 | |
| R&D Expense | $64M | $53M | $50M | $43M | $42M | $19M | |
| SG&A Expense | $427M | $237M | $109M | $45M | $25M | $8M | |
| Operating Expenses | $522M | $304M | $161M | $89M | $69M | $27M | |
| Operating Income | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M | |
| Interest Expense | · | · | $3M | $2M | $0 | · | |
| Other Non-op | $-202.0K | $-206.0K | $274.0K | $86.0K | $-73.0K | $0 | |
| Pretax Income | $-64M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Income Tax | $2M | $0 | $0 | $-4.0K | $55.0K | $1.0K | |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| EPS (Basic) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| Shares (Basic) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| Shares (Diluted) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| EBITDA | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $95M | $225M | $72M | $171M | $168M | |
| Short-term Investments | $234M | $197M | $2M | $145M | $483.0K | $0 | |
| Receivables | $85M | $47M | $17M | $0 | $0 | $0 | |
| Inventory | $4M | $3M | $3M | $0 | · | · | |
| Prepaid Expense | $13M | $15M | $8M | $5M | $4M | $2M | |
| Current Assets | $523M | $357M | $256M | $225M | $176M | $171M | |
| PP&E (Net) | $12M | $2M | $1M | $957.0K | $755.0K | $548.0K | |
| PP&E (Gross) | $14M | $4M | $3M | $2M | $976.0K | $682.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $546.0K | $221.0K | $134.0K | |
| Intangibles | $7M | $8M | $4M | $0 | · | · | |
| Other Non-current Assets | $2M | $999.0K | $2M | $585.0K | $1M | $81.0K | |
| Total Assets | $562M | $377M | $265M | $228M | $179M | $172M | |
| Accounts Payable | $16M | $9M | · | · | · | · | |
| Current Liabilities | $136M | $81M | $37M | $15M | $11M | $5M | |
| Capital Leases | $11M | $0 | $2M | $52.0K | $585.0K | $549.0K | |
| Other Non-current Liabilities | $11M | $0 | $2M | $100.0K | $699.0K | $605.0K | |
| Total Liabilities | $219M | $152M | $69M | $35M | $12M | $6M | |
| Long-term Debt | $72M | $72M | $30M | $19M | · | · | |
| Total Debt | $72M | $72M | $30M | $19M | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $770M | $585M | $442M | $302M | $213M | $199M | |
| Retained Earnings | $-427M | $-360M | $-245M | $-109M | $-47M | $-33M | |
| AOCI | $381.0K | $179.0K | $-2.0K | $-74.0K | $0 | · | |
| Stockholders' Equity | $343M | $225M | $197M | $193M | $167M | $166M | |
| Liabilities + Equity | $562M | $377M | $265M | $228M | $179M | $172M | |
| Shares Outstanding | 42,553,931 | 38,349,826 | 34,211,190 | 26,727,458 | 20,698,737 | 20,323,201 |
现金流 12
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $42M | $28M | $20M | $13M | $8M | $839.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $961.0K | $540.0K | $133.0K | $0 | · | · | |
| Operating Cash Flow | $-12M | $-83M | $-117M | $-49M | $4M | $-21M | |
| CapEx | $10M | $2M | $2M | $506.0K | $586.0K | $456.0K | |
| Investing Cash Flow | $-42M | $-199M | $141M | $-145M | $-586.0K | $-456.0K | |
| Debt Issued | $0 | $75M | $10M | $20M | · | · | |
| Net Debt Issued | $0 | $75M | · | · | · | · | |
| Financing Cash Flow | $143M | $155M | $130M | $94M | $21.0K | $132M | |
| Net Change in Cash | $89M | $-128M | $153M | $-100M | $3M | $110M | |
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M | $-22M | |
| Levered FCF | · | · | $-122M | $-52M | · | · |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | · | |
| Pretax Margin | -14.3% | -63.2% | -778.9% | -240.5% | -24.1% | · | |
| EBITDA Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| ROA | -14.1% | -36.0% | -55.1% | -30.5% | -7.9% | -23.3% | |
| ROE | -19.7% | -50.0% | -66.2% | -31.4% | -8.0% | -36.2% | |
| ROIC | -17.6% | -40.7% | -63.1% | -29.5% | -7.3% | · |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 | 31.7 | |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 | 31.2 | |
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | -42.8 | -28.5 | · | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.1 | 0.1 | 0.3 | · | |
| Receivables Turnover | 6.8 | 5.8 | 2.1 | · | · | · |
增长率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | 948.6% | -32.4% | -54.7% | · | · | |
| Revenue CAGR 3Y | 159.5% | 47.5% | · | · | · | · |
估值 (TTM) 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $183M | $17M | $26M | $57M | $0 | |
| Net Income TTM | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Market Cap | $3.48B | $2.12B | $693M | $392M | $466M | $840M | |
| Enterprise Value | $3.14B | $1.90B | $495M | $194M | · | · | |
| P/E | -51.5 | -18.0 | -4.4 | -5.8 | -33.6 | -9.6 | |
| P/S | 7.7 | 11.6 | 39.7 | 15.2 | 8.2 | · | |
| P/B | 10.1 | 9.5 | 3.5 | 2.0 | 2.8 | 5.1 | |
| P / Tangible Book | 10.4 | 9.8 | 3.6 | 2.0 | 2.8 | 5.1 | |
| P / Cash Flow | -279.8 | -25.6 | -5.9 | -8.0 | 124.3 | -39.7 | |
| P / FCF | -156.2 | -25.1 | -5.8 | -7.9 | 147.3 | -38.9 | |
| EV / EBITDA | -44.2 | -15.8 | -3.5 | -3.1 | · | · | |
| EV / FCF | -140.7 | -22.5 | -4.2 | -3.9 | · | · | |
| EV / Revenue | 7.0 | 10.4 | 28.4 | 7.5 | · | · | |
| Earnings Yield | -1.9% | -5.5% | -22.8% | -17.2% | -3.0% | -10.4% |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $162M | $152M | $119M | $103M | $78M | $66M | $48M | $41M | $28M | $13M | $2M | $0 | $2M | $10M | $0 | |
| Cost of Revenue | $12M | $9M | · | · | $6M | $5M | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| R&D Expense | $31M | $22M | $18M | $16M | $16M | $14M | $17M | $12M | $12M | $12M | $13M | $12M | $13M | $12M | $10M | $11M | |
| SG&A Expense | $151M | $136M | $131M | $109M | $103M | $85M | $69M | $58M | $59M | $52M | $43M | $30M | $20M | $15M | $15M | $12M | |
| Operating Expenses | $194M | $168M | $160M | $133M | $125M | $105M | $91M | $73M | $74M | $65M | $58M | $43M | $33M | $27M | $25M | $23M | |
| Operating Income | $-20M | $-6M | $-8M | $-15M | $-22M | $-26M | $-24M | $-25M | $-33M | $-38M | $-44M | $-41M | $-33M | $-25M | $-15M | $-23M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $983.0K | · | $858.0K | $815.0K | $684.0K | · | $633.0K | |
| Other Non-op | $-281.0K | $-87.0K | $-74.0K | $98.0K | $-145.0K | $-81.0K | $-27.0K | $67.0K | $-65.0K | $-181.0K | $363.0K | $-48.0K | $-47.0K | $6.0K | $-50.0K | $-7.0K | |
| Income Tax | $3M | $2M | · | · | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-5.0K | |
| Net Income | $-19M | $-7M | $-8M | $-13M | $-20M | $-25M | $-23M | $-23M | $-33M | $-36M | $-42M | $-39M | $-31M | $-23M | $-14M | $-23M | |
| EPS (Basic) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| EPS (Diluted) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| Shares (Basic) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| Shares (Diluted) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| EBITDA | $-20M | $-6M | · | $-15M | $-22M | $-26M | · | $-25M | $-33M | $-38M | · | $-41M | $-33M | $-25M | · | $-23M |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $102M | $184M | $113M | $97M | $176M | $95M | $176M | $181M | $194M | · | $227M | $107M | $66M | · | $169M | |
| Short-term Investments | $245M | $287M | $234M | $289M | $284M | $232M | $197M | $141M | $142M | $105M | · | $20M | $71M | $135M | · | $57M | |
| Receivables | $96M | $100M | $85M | $73M | $58M | $62M | $47M | $29M | $30M | $30M | · | $5M | · | $2M | · | $17.0K | |
| Inventory | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $4M | · | $15.0K | · | · | · | · | |
| Prepaid Expense | $10M | $27M | $13M | $22M | $29M | $6M | $15M | $7M | $6M | $7M | · | $6M | $5M | $5M | · | $3M | |
| Current Assets | $562M | $537M | $523M | $502M | $474M | $481M | $357M | $357M | $363M | $341M | · | $259M | $183M | $209M | · | $234M | |
| PP&E (Net) | $20M | $18M | $12M | $6M | $3M | $3M | $2M | $2M | $2M | $1M | · | $2M | $2M | $1M | · | $951.0K | |
| PP&E (Gross) | $22M | $20M | $14M | $8M | $6M | $5M | $4M | $4M | $4M | $3M | · | $3M | $2M | $2M | · | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $832.0K | $649.0K | · | $448.0K | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $4M | $4M | · | $4M | · | · | · | · | |
| Other Non-current Assets | $660.0K | $715.0K | $2M | $1M | $1M | $616.0K | $999.0K | $888.0K | $846.0K | $1M | · | $1M | $1M | $529.0K | · | $583.0K | |
| Total Assets | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Accounts Payable | $40M | $24M | $16M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $176M | $144M | $136M | $117M | $90M | $86M | $81M | $66M | $52M | $43M | · | $23M | $15M | $13M | · | $14M | |
| Capital Leases | $16M | $16M | $11M | $10M | $0 | $0 | · | $1M | $1M | $2M | · | $2M | $2M | · | · | $169.0K | |
| Other Non-current Liabilities | $16M | $16M | $11M | $10M | · | · | $0 | $1M | $1M | $2M | · | $2M | $2M | $40.0K | · | $209.0K | |
| Total Liabilities | $264M | $232M | $219M | $199M | $162M | $158M | $152M | $139M | $125M | $74M | · | $55M | $41M | $38M | · | $34M | |
| Long-term Debt | $73M | $73M | $72M | $72M | $72M | $72M | $72M | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Total Debt | $73M | $73M | · | $72M | $72M | $72M | · | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Paid-in Capital | $799M | $783M | $770M | $753M | $738M | $728M | $585M | $574M | $566M | $556M | · | $416M | $311M | $306M | · | $298M | |
| Retained Earnings | $-452M | $-434M | $-427M | $-418M | $-406M | $-385M | $-360M | $-337M | $-314M | $-280M | · | $-203M | $-164M | $-132M | · | $-95M | |
| AOCI | $-557.0K | $-298.0K | $381.0K | $289.0K | $39.0K | $85.0K | $179.0K | $346.0K | $-176.0K | $-63.0K | · | $-8.0K | $-23.0K | $-70.0K | · | $-10.0K | |
| Stockholders' Equity | $347M | $349M | $343M | $335M | $333M | $342M | $225M | $237M | $252M | $275M | $197M | $214M | $148M | $173M | $193M | $203M | |
| Liabilities + Equity | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Shares Outstanding | 43,271,347 | 43,021,312 | 42,553,931 | 42,447,882 | 42,210,972 | 41,995,537 | 38,349,826 | 38,196,072 | 38,030,385 | 37,749,468 | 34,211,190 | 33,104,087 | 26,899,572 | 26,800,512 | 26,727,458 | 26,671,812 |
现金流 13
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $14M | $12M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $200.0K | $240.0K | $321.0K | $200.0K | $200.0K | $240.0K | $240.0K | $100.0K | $100.0K | $100.0K | $133.0K | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $61M | $-25M | $19M | $18M | $-29M | $-21M | $-22M | $-9M | $-14M | $-38M | $-39M | $-32M | $-24M | $-22M | $-11M | $-19M | |
| CapEx | $4M | $6M | $6M | $2M | $1M | $590.0K | $72.0K | $282.0K | $1M | $174.0K | $0 | $375.0K | $787.0K | $340.0K | $127.0K | $96.0K | |
| Investing Cash Flow | $38M | $-59M | $49M | $-5M | $-52M | $-35M | $-60M | $3M | $-41M | $-102M | $18M | $47M | $64M | $11M | $-87M | $-57M | |
| Debt Issued | · | · | $0 | $0 | · | · | $0 | $0 | $75M | $0 | $0 | $5M | $0 | $5M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $5M | · | · | |
| Stock Issued | $0 | $0 | · | $0 | $-354.0K | $135M | · | $-43.0K | $-274.0K | $99M | · | $99M | $0 | $0 | · | $-218.0K | |
| Net Stock Activity | · | $0 | · | · | · | $135M | · | · | · | $99M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $1M | $2M | $3M | $2M | $137M | $3M | $639.0K | $42M | $109M | $20M | $105M | $510.0K | $5M | $264.0K | $-136.0K | |
| Net Change in Cash | $102M | $-82M | $71M | $16M | $-79M | $81M | $-79M | $-5M | $-13M | $-31M | $-2M | $120M | $41M | $-6M | $-98M | $-76M | |
| Taxes Paid | $3M | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-30M | · | · | · | $-21M | · | · | · | $-38M | · | · | · | $-22M | · | · |
盈利能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| Net Margin | -10.7% | -4.3% | · | -10.6% | -19.8% | -32.1% | · | -48.7% | -81.6% | -129.4% | · | -2092.4% | · | · | · | · | |
| EBITDA Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| ROA | -3.4% | -1.3% | · | -2.8% | -4.7% | -5.9% | · | -7.3% | -11.8% | -12.8% | · | -15.5% | -14.2% | -11.9% | · | -10.5% | |
| ROE | -5.5% | -2.0% | · | -4.4% | -7.0% | -8.1% | · | -10.4% | -16.7% | -15.9% | · | -18.8% | -17.0% | -14.5% | · | -11.8% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | · | 4.3 | 5.3 | 5.6 | · | 5.4 | 7.0 | 8.0 | · | 11.2 | 12.4 | 15.7 | · | 16.4 | |
| Quick Ratio | 3.1 | 3.4 | · | 4.1 | 4.9 | 5.4 | · | 5.3 | 6.8 | 7.7 | · | 10.8 | 12.1 | 15.4 | · | 15.9 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.3 | · | -47.7 | -40.3 | -36.5 | · | -36.2 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | 2.9 | 2.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.3 | 2.0 | · | 2.3 | 2.3 | 1.7 | · | 2.8 | 2.8 | 1.7 | · | 0.7 | · | · | · | 0.0 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $557M | $462M | · | $348M | $270M | $195M | · | $118M | $70M | $32M | · | $4M | $18M | $18M | · | $17M | |
| Net Income TTM | $-58M | $-65M | · | $-81M | $-102M | $-118M | · | $-132M | $-140M | $-130M | · | $-117M | $-83M | $-72M | · | $-64M | |
| Market Cap | $2.72B | $3.02B | · | $2.52B | $1.71B | $2.16B | · | $1.26B | $1.03B | $1.37B | · | $588M | $486M | $337M | · | $457M | |
| Enterprise Value | $2.35B | $2.70B | · | $2.19B | $1.40B | $1.82B | · | $1.01B | $782M | $1.10B | · | $371M | $332M | $160M | · | $249M | |
| P/E | -45.9 | -44.4 | · | -29.3 | -15.5 | -16.4 | · | -8.7 | -6.3 | -8.4 | · | -4.3 | -5.8 | -4.3 | · | -6.1 | |
| P/S | 4.9 | 6.5 | · | 7.3 | 6.3 | 11.1 | · | 10.6 | 14.7 | 42.9 | · | 134.6 | 27.3 | 18.4 | · | 26.8 | |
| P/B | 7.9 | 8.6 | · | 7.5 | 5.1 | 6.3 | · | 5.3 | 4.1 | 5.0 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Tangible Book | 8.0 | 8.8 | · | 7.7 | 5.3 | 6.5 | · | 5.5 | 4.2 | 5.1 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Cash Flow | · | -122.4 | · | · | · | -104.5 | · | · | · | -36.3 | · | · | · | -15.3 | · | · | |
| P / FCF | · | -99.0 | · | · | · | -101.6 | · | · | · | -36.1 | · | · | · | -15.1 | · | · | |
| EV / EBITDA | -117.9 | -441.3 | · | -150.9 | -63.2 | -69.3 | · | -40.2 | -23.5 | -29.3 | · | -9.1 | -10.1 | -6.4 | · | -10.9 | |
| EV / FCF | · | -88.7 | · | · | · | -85.7 | · | · | · | -29.1 | · | · | · | -7.2 | · | · | |
| EV / Revenue | 4.2 | 5.9 | · | 6.3 | 5.2 | 9.3 | · | 8.5 | 11.1 | 34.5 | · | 84.9 | 18.7 | 8.7 | · | 14.6 | |
| Earnings Yield | -2.2% | -2.2% | · | -3.4% | -6.4% | -6.1% | · | -11.5% | -16.0% | -11.9% | · | -23.5% | -17.3% | -23.4% | · | -16.5% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $451M | $183M | $17M | $26M | $57M |
| 营业利润率 % | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| 净收入 | $-66M | $-116M | $-136M | $-62M | $-14M |
| 稀释后每股收益 (EPS) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.2 | 0.3 | 0.2 | 0.1 | — |
| 流动比率 | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 |
| 速动比率 | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-22M | $-85M | $-119M | $-50M | $3M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 281 家申报者 · $2.2B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 46 (-4 与上一季度对比) | 32 (+1 与上一季度对比) | 102 (+14 与上一季度对比) | 75 (+2 与上一季度对比) | +3.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 21 位内幕人士 · 9 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Bobak R. Azamian | President/CEO and Board Chair | 2026年6月17日 S | 847991 | 0 | 2 | $-615489 |
| Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | 2026年6月15日 M | 56801 | 0 | 4 | $-1317002 |
| Leonard M. Greenstein | Chief Financial Officer | 2023年3月8日 A | — | 0 | 0 | $0 |
| Seshadri Neervannan | Chief Operating Officer | 2023年3月15日 M | 56577 | 0 | 0 | $0 |
| Aziz Mottiwala | Chief Commercial Officer | 2023年6月8日 S | 48086 | 0 | 0 | $0 |
| Bryan Wahl | General Counsel | 2023年3月15日 M | 18176 | 0 | 0 | $0 |
| Dianne C. Whitfield | Chief Human Resources Officer | 2023年3月15日 M | 12872 | 0 | 0 | $0 |
| Mark J. Holdbrook | V.P., Clinical Affairs | 2023年3月15日 M | 3577 | 0 | 0 | $0 |
| Jose M. Trevejo | Chief Medical Officer | 2023年3月15日 M | 8654 | 0 | 0 | $0 |
| Katherine Goodrich | 董事 | 2026年6月25日 A | 2233 | 0 | 1 | $-183384 |
| Andrew D. Goldberg | 董事 | 2026年6月25日 A | 19654 | 0 | 0 | $0 |
| Scott W Morrison | 董事 | 2026年6月25日 A | 7638 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | 董事 | 2026年6月25日 A | 11654 | 0 | 0 | $0 |
| William J Link PHD | 董事 | 2026年6月25日 A | 106786 | 0 | 10 | $-3500993 |
| Wendy L Yarno | 董事 | 2026年6月25日 A | 16654 | 0 | 0 | $0 |
| David E I Pyott | 董事 | 2026年6月25日 A | 1383 | 0 | 0 | $0 |
| Michael Ackermann | 董事 | 2022年6月15日 M | 1208273 | 0 | 0 | $0 |
| Elizabeth Yeu Lin | 董事 | 2021年12月31日 A | — | 0 | 0 | $0 |
| Rosemary A Crane | 董事 | 2021年8月11日 A | — | 0 | 0 | $0 |
| Jason E. Tester | 董事 | 2021年6月15日 A | 1920933 | 0 | 0 | $0 |
| Horowitz Limited Partnership VIII | 10% 所有者 | 2020年10月20日 C | 66172 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Horowitz Limited Partnership VIII, Horowitz Management, Inc., Adam S. Horowitz Revocable Trust, Jason E. Tester | 2020年10月30日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 50 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2.69% | 210454 SH | 2026年8月8日 | 每日 |
| SBIO · ALPS ETF Trust | 1.61% | 43870 NS | 2026年5月31日 | N-PORT |
| BBP · ETFis Series Trust I | 1.25% | 11632 NS | 2026年4月30日 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1.22% | 2469 NS | 2026年4月30日 | N-PORT |
| HAPS · Harbor ETF Trust | 1.19% | 29463 NS | 2026年4月30日 | N-PORT |
| IHE · iShares Trust | 0.57% | 141498 SH | 2026年8月8日 | 每日 |
| FYC · First Trust Exchange-Traded Alpha... | 0.40% | 66585 NS | 2026年4月30日 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund ... | 0.24% | 3915 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.20% | 295665 SH | 2026年8月8日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.19% | 2342 SH | 2026年8月8日 | 每日 |
| ESSC · Strategy Shares | 0.18% | 712 NS | 2026年4月30日 | N-PORT |
| IWO · iShares Trust | 0.17% | 379742 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.16% | 44912 SH | 2026年8月8日 | 每日 |
| FYX · First Trust Exchange-Traded Alpha... | 0.16% | 29611 NS | 2026年4月30日 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund ... | 0.13% | 1124 NS | 2026年5月31日 | N-PORT |
| BIB · ProShares Trust | 0.13% | 1573 NS | 2026年5月31日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.12% | 19431 NS | 2026年5月31日 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.11% | 40784 NS | 2026年4月30日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.10% | 1305 NS | 2026年4月30日 | N-PORT |
| SMLF · iShares Trust | 0.10% | 65431 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.10% | 11160 NS | 2026年4月30日 | N-PORT |
| IWM · iShares Trust | 0.09% | 1067848 SH | 2026年8月8日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.08% | 6209 NS | 2026年4月30日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.08% | 241028 SH | 2026年8月8日 | 每日 |
| ISCG · iShares Trust | 0.08% | 12043 SH | 2026年8月8日 | 每日 |
| RSSL · Global X Funds | 0.08% | 17152 NS | 2026年4月30日 | N-PORT |
| ITWO · ProShares Trust | 0.06% | 1862 NS | 2026年5月31日 | N-PORT |
| ESML · iShares Trust | 0.05% | 21718 SH | 2026年8月8日 | 每日 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 187238 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.04% | 1688 SH | 2026年8月8日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.04% | 1565 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.03% | 1456 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 14864 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 455389 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 89651 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.02% | 1476 NS | 2026年5月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 9169 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.02% | 6187 SH | 2026年8月8日 | 每日 |
| WSML · iShares Trust | 0.02% | 1892 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 1590 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 37 NS | 2026年5月31日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 13644 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 54981 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 9881 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 23482 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 636 NS | 2026年4月30日 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.00% | 18 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1295901 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3359 SH | 2026年8月8日 | 每日 |
| FTLS · First Trust Exchange-Traded Fund III | -0.03% | -12099 NS | 2026年4月30日 | N-PORT |